Dentsply Sirona (XRAY) EBITDA Margin (2009 - 2026)

Dentsply Sirona (XRAY) has reported EBITDA Margin for 18 consecutive years, with 9.13% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA Margin rose 2281.0% year-over-year to 9.13%; the trailing twelve-month figure through Jun 2026 stood at 8.51% (up 1971.0% YoY), and the FY2025 full-year result was 11.47%, up 1171.0% from the prior year.
• EBITDA Margin advanced to 9.13% in Q2 2026 per XRAY's latest filing, from 3.98% in the prior quarter.
• Across five years, EBITDA Margin topped out at 11.63% in Q2 2022 and bottomed at 128.62% in Q3 2022.
• Historically, EBITDA Margin has averaged 13.65% across 5 years, with a median of 2.1% in 2023.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 14131 bps in 2022, then jumped 10370 bps in 2023.
• Over 5 years, EBITDA Margin stood at 6.61% in 2022, then rose by 9 bps to 7.21% in 2023, then sank by 880 bps to 56.24% in 2024, then soared by 74 bps to 14.46% in 2025, then soared by 163 bps to 9.13% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 9.13%, 3.98%, and 14.46% for Q2 2026, Q1 2026, and Q4 2025 respectively.